<DOC>
	<DOCNO>NCT00249288</DOCNO>
	<brief_summary>This study aim examine factor potentially contribute difference blood folate , homocysteine B12 level schizophrenia patient , test hypothesis low folate associate negative symptom , examine efficacy folate supplementation reduce negative symptom .</brief_summary>
	<brief_title>Folate Supplementation Schizophrenia</brief_title>
	<detailed_description>This study three-month , placebo-controlled trial folate 2mg/d 50 schizophrenia patient score least 3 ( moderate great severity ) least one SANS global assessment subscales , exception attention global assessment subscale . The specific aim study : - To examine factor potentially contribute difference blood folate , homocysteine B12 level patient baseline , include dietary intake cigarette smoking . - To test hypothesis low folate associate negative symptom examine correlation red blood cell folate concentration clinical rating negative symptom compare folate concentration deficit syndrome versus non-deficit syndrome patient . We also control dietary intake cigarette smoke , gender , age . - To examine efficacy folate supplementation reduce negative symptom</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>1 . Schizophrenia , subtype 2 . Ages 1868 3 . Male female 4 . A score least 3 ( moderate great severity ) least one SANS global assessment subscales , exception attention global assessment subscale 5 . Stable antipsychotic dose &gt; 6 week 6 . Capable provide informed consent 1 . Unstable medical illness 2 . Substance abuse 3 . Megaloblastic anemia 4 . Nonenglish speaking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Negative Symptoms</keyword>
	<keyword>Folate</keyword>
</DOC>